Newly-released qPCR Instruments Market industry analysis report by Future Market Insights shows that global sales of the qPCR Instruments Market in 2022 were held at US$ 1.2 Billion. With a CAGR of 3.5% from 2023 to 2033, the market is projected to reach a valuation of US$ 1.8 Billion. The GeneXpert instrument is expected to be the highest revenue-generating segment, projected to account for a CAGR of 3.5% from 2023 to 2033.
| Attribute | Details |
|---|---|
| Global Qpcr Instruments Market (2023) | US$ 1.3 Billion |
| Global Qpcr Instruments Market (2033) | US$ 1.8 Billion |
| Global Qpcr Instruments Market CAGR (2023 to 2033) | 3.5% |
| USA Qpcr Instruments Market CAGR (2023 to 2033) | 3.7% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the qPCR Instruments Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value increased at a CAGR of 3.1%, wherein, countries such as the USA, United kingdom China, Japan and South Korea held a significant share in the global market.
The market reached a valuation of US$ 1.2 Billion in 2022. Future Market Insights estimates that the revenue will grow approximately 1.5x from 2023 to 2033, reaching nearly US$ 1.8 Billion by 2033.
Real-Time PCR is created as an exact, effective, and fast approach to nucleic acid detection using conventional Polymerase Chain Reaction (PCR) innovation with a few enhancements.
Real-Time PCR contains nucleic acid detection as well as identification in only one stage. It can use less starting material than conventional PCR. The template DNA is detected in real-time, using PCR output that is intensified over the threshold value of the cycle (Ct numbers) plus the background.
Far not quite the same as the previous end-point strategy for standard PCR procedures, Real-Time PCR can be quantitative on the grounds that the PCR item is distinguished by involving fluorescent colors continuously. Accordingly, Real-Time PCR procured the substitute and particular name of Quantitative PCR or qPCR.
Research, medical care, and diagnosis can all be improved using the theory of polymerase chain reaction (PCR). As the idea of "beating" small quantities many times in a short amount of time becomes more evident, mRNA expression can consequently be enhanced with the help of real-time PCR equipment.
qPCR devices are utilized extensively in a range of applications, such as phenotyping, genotyping; and epigenetic research. They are also helpful in discovering safe and efficient usage of medications, particularly in examining mRNA or discovering the association between disease and pathological developments such as illness.
Some delivery systems are regarded as a type of demonstrative instrument. PCR machines are among the leading diagnostic tools in the world, as they are among the fastest to deliver accurate data about a patient’s health.
The global increase in the prevalence of SARS-CoV-2 contaminations is driving interest in qPCR devices and consumables. As the frequency goes up, the quantity of preventive screenings is projected to upscale too. This is due to the way that countries cannot estimate the number of COVID-19 patients without screening them. Over the projected period, the market is expected to be driven by rising ailment commonness, mechanical advances, and expanded interest in qPCR instruments.
These improvements are projected to expand the accessibility of point-of-care atomic demonstrative testing, bringing about quicker and more precise test discoveries. For instance, Biomolecular Systems' Mic qPCR gear weighs around 2 kilos, making it very convenient and simple to utilize. QuantStudio 5 Dx Real-Time PCR System, on the other hand offers improved work processes and high-volume testing for quicker results.
Additional advantages incorporate expense adequacy and smoothed out programming. Besides, the instrument's freedom in excess of 50 countries can help market extension. The instrument likewise incorporates research-led diagnostics measures, giving it an upper hand. As a result of the presence of computerized PCR devices that are further developed and precise, the market faces a high gamble of outer other options.
Coronavirus has upgraded the number of diagnostic devices that can be utilized. In affluent economies, further developed PCR strategies, like dPCR, are utilized since they can help lower misleading positive rates. The improvement of viable qPCR instruments could decrease the danger of gadget replacement and lift market development. The expanded spotlight on diagnostics due to COVID-19's development is expected to drive interest in qPCR instruments later in the years.
Principal Consultant
By enhancing little objective particles a few times throughout a brief timeframe, qPCR Instruments help in the distinguishing identification of small target molecules. qPCR instruments are broadly used across several applications, including quality articulation examination, genotyping, and epigenetics research. They are likewise helpful in the disclosure of new prescriptions as they can be utilized to evaluate mRNA levels or recognize transformations connected to illnesses like malignant growth.
For the production of novel meds, the qPCR instrument is utilized. qPCR instruments can be utilized to decide the amount of quality or mRNA available in a cell. A suitable test is utilized to make these estimations. Researchers can utilize the information given by this system to more readily comprehend how qualities work all through sickness processes and to assemble more successful therapies.
Chronic diseases, viral sicknesses, and hereditary problems like Alzheimer's, Turner disorder, and Parkinson's have expanded in commonness, which is projected to drive market extension. Ongoing illnesses like malignant growth, diabetes, kidney sickness, and respiratory issues, including asthma, represent seven out of 10 fatalities in the United States every year, as per the CDC. With PCR, illnesses can be recognized all the more rapidly, considering more convenient and reasonable treatments.
The market is projected to ascend as qPCR innovation becomes more widely adopted. Because of their accuracy, computerization, careful outcomes, continuous measurement, and awareness, qPCR methods are turning out to be more well-known. Since qPCR acknowledges a wide range of nucleic acids as inputs, it is a successful and important technique in research.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
North America accounted for a significant share of the market and is expected to grow at a CAGR of 3.6% during the forecast period. The growing administrative support and expanding dispatches of novel medicines are responsible for the development of the regional market.
USA is expected to account for a significant market with a CAGR of 3.7%. Over the projected term, it is expected to continue its advantage. The growing administrative support and expanding dispatches of novel prescriptions are inferable from the development of this market.
The market in the United kingdom is expected to reach a valuation of US$ 72.9 Billion by 2033. Growing with a CAGR of 3.8% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around US$ 22.6 Million.
In Japan, the market is expected to grow at a CAGR of 4.2% from 2023 to 2033, reaching around US$ 76.4 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of US$ 25.8 Million during the forecast period.
The market in South Korea is expected to reach a valuation of around US$ 39.4 Million by 2033, growing at a CAGR of 4% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around US$ 12.7 Million.
The GeneXpert segment accounts for a significant revenue share and is projected to increase at a CAGR of 3.5% during the forecast period. This is due to the rising demand for infection diagnosis throughout the pandemic. This system features quick turnaround times, flexible procedures, and intuitive designs 24 hours a day, seven days a week.
Lab instruments can be operated on an individual, expandable, compact, and self-contained workstation. It possesses touchscreen control, adjustable strength, improved accumulator capacity, a larger conveyor and loading zone, a longer test shuttle, and more. This equipment also includes a robotic gantry, quicker and quieter in operation, that has a much longer operating life compared with other gantries available.
The key players operating in the market include Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Abbott, Qiagen, Azure Biosystems Inc., and Quantabio.
Similarly, recent developments related to companies offering QPCR Instruments Market have been tracked by the team at Future Market Insights, which are available in the full report.
The qPCR instruments market is set to reach US$ 1.3 billion in 2023.
The global qPCR instruments market is poised to achieve US$ 1.8 billion by 2033.
A CAGR of 3.5% is predicted for the qPCR instruments market through 2033.
The United States showcases significant revenue potential for qPCR instruments.
The GeneXpert segment is set to lead the market with a projected CAGR of 3.5%.
1. Executive Summary | qPCR Instruments Market
1.1. Global Market Outlook
1.2. Summary of Statistics
2. 1.3.hKey Market Characteristics & Attributes
2.1. Analysis and Recommendations
3. Market Overview
3.1. Market Coverage / Taxonomy
3.2. Market Definition / Scope / Limitations
4. Market Risks and Trends Assessment
4.1. Risk Assessment
4.1.1. COVID-19 Crisis and Impact of COVID-19 Market
4.1.2. COVID-19 Impact Benchmark with Previous Crisis
4.1.3. Impact on Market Value (US$ Million)
4.1.4. Assessment by Key Countries
4.1.5. Assessment by Key Market Segments
4.1.6. Action Points and Recommendation for Suppliers
4.2. Key Trends Impacting the Market
4.3. Formulation and Product Development Trends
5. Market Background and Foundation Data Points
5.1. Global Market (US$ Million)
5.2. Market Opportunity Assessment (US$ Million)
5.2.1. Total Available Market
5.2.2. Serviceable Addressable Market
5.2.3. Serviceable Obtainable Market
5.3. Market Scenario Forecast
5.3.1. Demand in optimistic Scenario
5.3.2. Demand in Likely Scenario
5.3.3. Demand in Conservative Scenario
5.4. Investment Feasibility Analysis
5.4.1. Investment in Established Markets
5.4.1.1. In Short Term
5.4.1.2. In Long Term
5.4.2. Investment in Emerging Markets
5.4.2.1. In Short Term
5.4.2.2. In Long Term
5.5. Forecast Factors - Relevance & Impact
5.5.1. Top Companies Historical Growth
5.5.2. Global Market Growth
5.5.3. Adoption Rate, by Country
5.6. Market Dynamics
5.6.1. Market Driving Factors and Impact Assessment
5.6.2. Prominent Market Challenges and Impact Assessment
5.6.3. Market Opportunities
5.6.4. Prominent Trends in the Global Market & Their Impact Assessment
6. Key Success Factors
6.1. Manufacturers’ Focus on Low Penetration High Growth Markets
6.2. Banking on with Segments High Incremental Opportunity
6.3. Peer Benchmarking
7. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Analysis, 2018 to 2022
7.2. Current and Future Market Projections, 2023 to 2033
7.3. Y-o-Y Growth Trend Analysis
8. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Instrument Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Instrument Type, 2018 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Instrument Type, 2023 to 2033
9.3.1. 7500
9.3.2. QuantStudioDx Real-Time PCR System
9.3.3. QuantStudio 5 Real-Time PCR System
9.3.4. ViiA 7 Dx
9.3.5. StepOne/ StepOne Plus
9.3.6. LightCycler 2.0/ 96/ 480/ 1536
9.3.7. Cobas 4800
9.3.8. SmartCycler
9.3.9. GeneXpert
9.3.10. Rotor-Gene Q 5Plex HRM System
9.3.11. Others
9.4. Market Attractiveness Analysis By Instrument Type
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis By Region, 2018 to 2022
10.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2023 to 2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
11.4.1. By Country
11.4.1.1. USA
11.4.1.2. Canada
11.4.2. By Instrument Type
11.5. Market Attractiveness Analysis
11.5.1. By Country
12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Instrument Type
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Instrument Type
13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. France
13.4.1.3. United kingdom
13.4.1.4. Italy
13.4.1.5. Benelux
13.4.1.6. Nordic Countries
13.4.1.7. Rest of Europe
13.4.2. By Instrument Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Instrument Type
14. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
14.4.1. By Country
14.4.1.1. China
14.4.1.2. Japan
14.4.1.3. South Korea
14.4.1.4. Rest of Asia Pacific
14.4.2. By Instrument Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Instrument Type
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
15.4.1. By Country
15.4.1.1. GCC Countries
15.4.1.2. South Africa
15.4.1.3. Turkey
15.4.1.4. Rest of Middle East and Africa
15.4.2. By Instrument Type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Instrument Type
16. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.1.1. Market Value Proportion Analysis, By Key Countries
16.1.2. Global Vs. Country Growth Comparison
16.2. US Market Analysis
16.2.1. Value Proportion Analysis by Market Taxonomy
16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.2.2.1. By Instrument Type
16.3. Canada Market Analysis
16.3.1. Value Proportion Analysis by Market Taxonomy
16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.3.2.1. By Instrument Type
16.4. Mexico Market Analysis
16.4.1. Value Proportion Analysis by Market Taxonomy
16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.4.2.1. By Instrument Type
16.5. Brazil Market Analysis
16.5.1. Value Proportion Analysis by Market Taxonomy
16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.5.2.1. By Instrument Type
16.6. Germany Market Analysis
16.6.1. Value Proportion Analysis by Market Taxonomy
16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.6.2.1. By Instrument Type
16.7. France Market Analysis
16.7.1. Value Proportion Analysis by Market Taxonomy
16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.7.2.1. By Instrument Type
16.8. Italy Market Analysis
16.8.1. Value Proportion Analysis by Market Taxonomy
16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.8.2.1. By Instrument Type
16.9. BENELUX Market Analysis
16.9.1. Value Proportion Analysis by Market Taxonomy
16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.9.2.1. By Instrument Type
16.10. UK Market Analysis
16.10.1. Value Proportion Analysis by Market Taxonomy
16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.10.2.1. By Instrument Type
16.11. Europe Market Analysis
16.11.1. Value Proportion Analysis by Market Taxonomy
16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.11.2.1. By Instrument Type
16.12. China Market Analysis
16.12.1. Value Proportion Analysis by Market Taxonomy
16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.12.2.1. By Instrument Type
16.13. Japan Market Analysis
16.13.1. Value Proportion Analysis by Market Taxonomy
16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.13.2.1. By Instrument Type
16.14. South Korea Market Analysis
16.14.1. Value Proportion Analysis by Market Taxonomy
16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.14.2.1. By Instrument Type
16.15. GCC Countries Market Analysis
16.15.1. Value Proportion Analysis by Market Taxonomy
16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.15.2.1. By Instrument Type
16.16. South Africa Market Analysis
16.16.1. Value Proportion Analysis by Market Taxonomy
16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.16.2.1. By Instrument Type
16.17. Turkey Market Analysis
16.17.1. Value Proportion Analysis by Market Taxonomy
16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.17.2.1. By Instrument Type
16.17.3. Competition Landscape and Player Concentration in the Country
17. Market Structure Analysis
17.1. Market Analysis by Tier of Companies
17.2. Market Concentration
17.3. Market Share Analysis of Top Players
17.4. Market Presence Analysis
17.4.1. By Regional footprint of Players
17.4.2. Product footprint by Players
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
18.3.1. Thermo Fisher Scientific
18.3.1.1. Overview
18.3.1.2. Product Portfolio
18.3.1.3. Sales Footprint
18.3.1.4. Strategy Overview
18.3.2. Abbott
18.3.3. F.Hoffmann-La Roche Ltd.
18.3.4. Danaher Corporation
18.3.5. Agilent Technologies
18.3.6. Qiagen
18.3.7. Azure Biosystems Inc.
18.3.8. Quantabio
19. Assumptions and Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
qPCR Instruments Market
